1. Home
  2. TELA vs BHM Comparison

TELA vs BHM Comparison

Compare TELA & BHM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TELA
  • BHM
  • Stock Information
  • Founded
  • TELA 2012
  • BHM 2022
  • Country
  • TELA United States
  • BHM United States
  • Employees
  • TELA N/A
  • BHM N/A
  • Industry
  • TELA Medical/Dental Instruments
  • BHM Real Estate Investment Trusts
  • Sector
  • TELA Health Care
  • BHM Real Estate
  • Exchange
  • TELA Nasdaq
  • BHM Nasdaq
  • Market Cap
  • TELA 63.0M
  • BHM 51.9M
  • IPO Year
  • TELA 2019
  • BHM N/A
  • Fundamental
  • Price
  • TELA $1.53
  • BHM $11.45
  • Analyst Decision
  • TELA Buy
  • BHM Strong Buy
  • Analyst Count
  • TELA 3
  • BHM 1
  • Target Price
  • TELA $5.33
  • BHM $15.00
  • AVG Volume (30 Days)
  • TELA 105.0K
  • BHM 3.5K
  • Earning Date
  • TELA 11-06-2025
  • BHM 01-01-0001
  • Dividend Yield
  • TELA N/A
  • BHM 4.36%
  • EPS Growth
  • TELA N/A
  • BHM N/A
  • EPS
  • TELA N/A
  • BHM N/A
  • Revenue
  • TELA $75,323,000.00
  • BHM $71,496,000.00
  • Revenue This Year
  • TELA $25.72
  • BHM N/A
  • Revenue Next Year
  • TELA $22.03
  • BHM N/A
  • P/E Ratio
  • TELA N/A
  • BHM N/A
  • Revenue Growth
  • TELA 16.34
  • BHM 27.87
  • 52 Week Low
  • TELA $0.86
  • BHM $9.30
  • 52 Week High
  • TELA $3.26
  • BHM $16.37
  • Technical
  • Relative Strength Index (RSI)
  • TELA 51.74
  • BHM N/A
  • Support Level
  • TELA $1.47
  • BHM N/A
  • Resistance Level
  • TELA $1.60
  • BHM N/A
  • Average True Range (ATR)
  • TELA 0.09
  • BHM 0.00
  • MACD
  • TELA 0.01
  • BHM 0.00
  • Stochastic Oscillator
  • TELA 68.55
  • BHM 0.00

About TELA TELA Bio Inc.

TELA Bio Inc a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.

About BHM Bluerock Homes Trust Inc.

Bluerock Homes Trust Inc owns and operates a portfolio of institutional residential properties including single-family homes, build-to-rent communities, and other residential communities located in attractive markets with a focus on the knowledge-economy and high-quality of life growth markets of the Sunbelt and Western United States. The company's principal objective is to generate attractive risk-adjusted returns on investments where it believes it can drive growth in funds from operations and net asset value by acquiring residential units, developing residential communities, and through value-add renovations. The Company is an externally managed REIT managed and advised by Bluerock Homes Manager, LLC.

Share on Social Networks: